The new face in our wallet for those of us fortunate enough to carry £50 notes should be that of a woman scientist, according to the chief scientific officer of the UK's pharma trade body.<
Janssen Biotech has bought Yuhan’s Lazertinib, a novel clinical-stage therapeutic candidate for the treatment of patients with non-small cell lung cancer (NSCLC).
Health and social care secretary Matt Hancock today unveils his long-term NHS plan, which focuses on people taking greater responsibility for their health, and recommends genetic technology
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
